Infectious Disorders - Drug Targets

Formerly Current Drug Targets - Infectious Disorders


Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Cited Article

A Review on Free Radicals and Antioxidants

Volume:20   Issue:1
Pp: 16-26
Hourieh Alkadi*
DOI: 10.2174/1871526518666180628124323

Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients

Volume:20   Issue:4
Pp: 407-408
Cédric ANNWEILER, Zhijian CAO, Yingliang WU, Emmanuelle FAUCON, Stéphanie MOUHAT, Hervé KOVACIC and Jean-Marc SABATIER
DOI: 10.2174/1871526520666200518073329

A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case

Volume:20   Issue:4
Pp: 559-562
Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan and Seyed Ahmad Seyed Alinaghi*
DOI: 10.2174/1871526520666200429115535

SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments

Volume:20   Issue:3
Pp: 348-349
Zhijian Cao, Yingliang Wu, Emmanuelle Faucon and Jean-Marc Sabatier
DOI: 10.2174/1871526520999200505174704

Hand Hygiene Compliance and Effectiveness Against Respiratory Infections Among Hajj Pilgrims: A Systematic Review

Volume:20   Issue:3
Pp: 273-283
Amani S. Alqahtani, Mutaz Fakeerh, Daniah Bondagji, Silvia Park, Anita E. Heywood, Kerrie E. Wiley, Robert Booy and Harunor Rashid*
DOI: 10.2174/1871526518666181001145041

Hepatitis C Virus: Efficacy of New DAAs Regimens

Volume:20   Issue:2
Pp: 143-149
Amal Ahmed Mohamed, Naglaa El-Toukhy Ramadan El-Toukhy, Ebada Mohamed Said, Hoda Mohamed Rabie Gabal, Hossameldin AbdelAziz, Wahid Doss, Hadeel El-Hanafi, Hala H. El Deeb, Seham Mahmoud, Mahmoud Elkadeem, Hassan Salama Shalby and Sherief Abd-Elsalam*
DOI: 10.2174/1871526519666190121114003

Repurposing of Existing Drugs for the Bacterial Infections: An In silico and In vitro Study

Volume:20   Issue:2
Pp: 182-197
Yachika Kapoor, Ruchika Sharma and Anoop Kumar*
DOI: 10.2174/1871526519666181126094244

High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals

Volume:20   Issue:2
Pp: 223-228
Mahmoud Khodabandeh, Mohsen Mohammadi , Mohammad Reza Abdolsalehi, Meysam Hasannejad-Bibalan , Mehrdad Gholami , Azadeh Alvandimanesh, Abazar Pournajaf and Ramazan Rajabnia*
DOI: 10.2174/1871526519666181130095954

Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital

Volume:20   Issue:3
Pp: 350-350
Fereshteh Ghiasvand and SeyedAhmad SeyedAlinaghi
DOI: 10.2174/1871526520999200520173216

Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection

Volume:20   Issue:3
Pp: 389-395
Ossama A. Ahmed, Mohamed A Elsebaey, Mohamed Hassan A. Fouad, Mahmoud Elkadeem, Rehab Badawi, Ahmed Khayyal, Shaimaa Soliman, Manal Saad Negm and Sherief Abd-Elsalam*
DOI: 10.2174/1871526519666181218104600

Defining ‘Satisfactory Response’ to Therapy in Abdominal Tuberculosis: A Work in Progress

Volume:20   Issue:2
Pp: 111-114
Vishal Sharma *, Harjeet Singh and Harshal S. Mandavdhare
DOI: 10.2174/1871526518666181022111323

Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies

Volume:20   Issue:4
Pp: 409-422
Monu Yadav*, Ishu Sardana, Amarjeet Sharma , Nidhi Sharma, Kalpana Nagpal* and Paramjeet Malik
DOI: 10.2174/1871526519666190617162701

Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison

Volume:20   Issue:6
Pp: 778-783
Behnam Farhoudi, SeyedAhmad SeyedAlinaghi*, Bahar Ataeinia, Mostafa Hosseini, Sirous Jafari, Ramin Alasvand, Mehrzad Tashakoriyan and Minoo Mohraz
DOI: 10.2174/1871526519666191015151639